Gerard Griffioen
Chief Tech/Sci/R&D Officer at reMYND NV
Gerard Griffioen active positions
| Companies | Position | Start | End |
|---|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Gerard Griffioen
Former positions of Gerard Griffioen
| Companies | Position | Start | End |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Training of Gerard Griffioen
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistics
International
| Belgium | 3 |
| Netherlands | 2 |
| Austria | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Stock Market
- Insiders
- Gerard Griffioen
- Experience
